Michael Hesney
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- HIV/AIDS drug development and treatment 5
- Antifungal resistance and susceptibility 3
- Surgery 6
- Nausea and vomiting management 4
- Co-authors
- Paul Deutsch (9 shared papers)Scott A. Waldman (5 shared papers)Julie A. Stone (4 shared papers)Andrew Sterrett (3 shared papers)Howard Greenberg (3 shared papers)Gregory A. Winchell (4 shared papers)Peter Wickersham (3 shared papers)Anup Majumdar (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)The Journal of Clinical Pharmacology (3 papers)Journal of Hepatology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Michael Hesney
25 papers receiving 865 citations
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 59
- Molecular Medicine 109
- Infectious Diseases 380
- Pharmacology 291
- Virology 60
Countries citing papers authored by Michael Hesney
This map shows the geographic impact of Michael Hesney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hesney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hesney more than expected).
Fields of papers citing papers by Michael Hesney
This network shows the impact of papers produced by Michael Hesney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hesney. The network helps show where Michael Hesney may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hesney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 208 | |
| 2 | 2002 | 129 | |
| 3 | 1998 | 100 | |
| 4 | 2003 | 75 | |
| 5 | 2006 | 74 | |
| 6 | 2007 | 49 | |
| 7 | 1998 | 38 | |
| 8 | 2006 | 35 | |
| 9 | 1991 | 34 | |
| 10 | 2003 | 29 | |
| 11 | 1990 | 26 | |
| 12 | 1984 | 23 | |
| 13 | Drug interactions between caspofungin and tacrolimus | 2001 | 17 |
| 14 | Effect of hepatic insufficiency on the pharmacokinetics of caspofungin | 2001 | 12 |
| 15 | Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. | 1985 | 12 |
| 16 | The tolerability profile of prophylactic norfloxacin in neutropenic patients. | 1988 | 6 |
| 17 | 2015 | 5 | |
| 18 | 1992 | 5 | |
| 19 | 2000 | 4 | |
| 20 | 1990 | 4 |
About Michael Hesney
Michael Hesney is a scholar working on Infectious Diseases, Surgery, Pharmacology, Hepatology and Epidemiology, having authored 25 papers that have together received 896 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), HIV/AIDS drug development and treatment (5 papers), Hepatitis C virus research (4 papers), Nausea and vomiting management (4 papers), Antifungal resistance and susceptibility (3 papers), Antibiotic Use and Resistance (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (59 citations), Molecular Medicine (109 citations), Infectious Diseases (380 citations), Pharmacology (291 citations) and Virology (60 citations). Michael Hesney has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Paul Deutsch, Scott A. Waldman, Julie A. Stone, Andrew Sterrett, Howard Greenberg, Gregory A. Winchell, Peter Wickersham, Anup Majumdar, Sherry D. Holland and Michael S. Schwartz. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Clinical Pharmacology, Journal of Hepatology, Clinical Pharmacology & Therapeutics and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.